An investigation on behalf of investors in Avon Products, Inc. (NYSE: AVP) shares over potential wrongdoing at Avon Products, Inc. was announced.
San Diego, CA -- (SBWIRE) -- 02/14/2019 -- An investigation was announced for investors in shares of Avon Products, Inc. (NYSE: AVP) concerning potential breaches of fiduciary duties.
Investors who purchased shares of Avon Products, Inc. (NYSE: AVP) and currently hold any of those NYSE: AVP shares have certain options and should contact the Shareholders Foundation at firstname.lastname@example.org or call +1(858) 779 - 1554.
London based Avon Products, Inc. manufactures and markets beauty and related products in Europe, the Middle East, Africa, south Latin America, north Latin America, and the Asia Pacific. The investigation by a law firm concerns whether Avon engaged in a deliberate revenue scheme to artificially inflate its reported sales in foreign markets, consequently boosting Avon's share price which allowed the company to raise hundreds of millions of dollars in capital via a public debt offering.
Those who purchased shares of Avon Products, Inc. (NYSE: AVP), have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
For more information on this press release visit:
Media Relations Contact
Email: Click to Email Michael Daniels